Internal Medicine, Infectious Disease · Bronx, NY
NPI
1013171859
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
2015 Grand Concourse, Essen Medical Associates PC
Bronx, NY, 10453
Phone (718) 299-7295
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
295 services
Medicare patients, 2024
110
Average age 71
Drug cost, 2024
$4.4M
4,551 prescriptions
Company payments, 2025
$221
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kaniz N Banu was code 99233 (hospital e&m - subsequent), 99 times for 41 patients. In total Kaniz N Banu billed 295 services in 14 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 99 | 41 | $104.83 | $10K |
| 99222 Hospital E&M - Initial | Facility | 61 | 57 | $116.62 | $7,114 |
| 99214 Office E&M - Established | Facility | 53 | 21 | $78.48 | $4,160 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $153.46 | $1,995 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 11 | $64.53 | $839 |
| 99215 Office E&M - Established | Facility | 13 | 11 | $95.65 | $1,243 |
| 99221 Hospital E&M - Initial | Facility | 11 | 11 | $67.52 | $743 |
By year: 2022 $7,598 for 84 services; 2023 $8,381 for 118 services; 2024 $28K for 295 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kaniz N Banu prescribed most often to Medicare patients was Atorvastatin Calcium, with 354 prescriptions and refills. In total Kaniz N Banu wrote 4,551 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 354 | 429 | 55 | $1,574 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 324 | 324 | 46 | $1.2M |
| Dovato Dolutegravir Sodium/Lamivudine | 201 | 201 | 20 | $558K |
| Juluca Dolutegravir/Rilpivirine | 193 | 213 | 27 | $705K |
| Amlodipine Besylate Generic | 157 | 196 | 34 | $610 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 143 | 154 | 25 | $4,907 |
| Alendronate Sodium Generic | 112 | 121 | 17 | $302 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 110 | 114 | 16 | $402K |
| Rosuvastatin Calcium Generic | 105 | 157 | 16 | $784 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 101 | 129 | 13 | $607 |
| Nifedipine Er Nifedipine | 97 | 127 | 15 | $1,337 |
| Folic Acid Generic | 96 | 102 | 15 | $56.29 |
| Enalapril Maleate Generic | 92 | 115 | 16 | $835 |
| Descovy Emtricitabine/Tenofov Alafenam | 87 | 87 | 15 | $183K |
| Glimepiride Generic | 83 | 101 | 11 | $274 |
Brand drugs: 1,788 claims; generic drugs: 2,691 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kaniz N Banu $221 ($221 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $186.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.